J. M. Hall

发表

D. McDonnell, J. M. Hall, 2004, Canadian Medical Association Journal.

J. M. Hall, Callie W. Greco, 2020, Dictionary of Trade Policy Terms.

The nuclear receptor-coactivator interaction surface as a target for peptide antagonists of the peroxisome proliferator-activated receptors.

M. Dwyer, T. Stanley, John E. Allen, 2007, Molecular endocrinology.

Differential Interaction of the Methoxychlor Metabolite 2,2-Bis-(p-Hydroxyphenyl)-1,1,1-Trichloroethane with Estrogen Receptors α and β1.

S. Safe, K. Gaido, S. Maness, 1999, Endocrinology.

COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms

Xi-Ping Huang, B. Roth, D. Ricke, 2020, Frontiers in Pharmacology.

Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells.

K. Korach, J. M. Hall, 2003, Molecular endocrinology.

Research Resource: STR DNA profile and gene expression comparisons of human BG-1 cells and a BG-1/MCF-7 clonal variant.

K. Korach, Liwen Liu, S. Burkett, 2014, Molecular endocrinology.

The Multifaceted Mechanisms of Estradiol and Estrogen Receptor Signaling*

K. Korach, J. F. Couse, Kenneth S. Korach, 2001, The Journal of Biological Chemistry.

Analysis of the molecular mechanisms of human estrogen receptors alpha and beta reveals differential specificity in target promoter regulation by xenoestrogens.

K. Korach, J. M. Hall, 2002, The Journal of biological chemistry.

The Estrogen Receptor ␤-isoform (er␤) of the Human Estrogen Receptor Modulates Er␣ Transcriptional Activity and Is a Key Regulator of the Cellular Response to Estrogens and Antiestrogens*

D. McDonnell, J. M. Hall, 2022 .

Update on animal models developed for analyses of estrogen receptor biological activity

K. Korach, J. Harrell, J. F. Couse, 2003, The Journal of Steroid Biochemistry and Molecular Biology.

Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation.

Russell S. Thomas, D. Kazmin, D. McDonnell, 2010, Molecular endocrinology.

Endocrine disrupting chemicals promote the growth of ovarian cancer cells via the ER‐CXCL12‐CXCR4 signaling axis

K. Korach, J. M. Hall, 2013, Molecular carcinogenesis.

The Role of Dietary Phytoestrogens and the Nuclear Receptor PPARγ in Adipogenesis: An in Vitro Study

K. Korach, J. M. Hall, Heather R. Powell, 2019, Environmental health perspectives.

Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting.

D. McDonnell, J. M. Hall, 2005, Molecular interventions.

Dual Proteolytic Pathways Govern Glycolysis and Immune Competence

W. Lu, V. Korolchuk, David McDonald, 2014, Cell.

Peroxisome Proliferator-Activated Receptor as a Therapeutic Target in Human Breast Cancer

Matthew Robinson, J. M. Hall, 2015 .

Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements.

K. Korach, D. McDonnell, J. M. Hall, 2002, Molecular endocrinology.

Paralogous vitamin D receptors in teleosts: transition of nuclear receptor function.

L. Moore, S. Kullman, D. Hinton, 2008, Endocrinology.

Analysis of the Molecular Mechanisms of Human Estrogen Receptors α and β Reveals Differential Specificity in Target Promoter Regulation by Xenoestrogens*

K. Korach, J. M. Hall, 2002, The Journal of Biological Chemistry.

Perturbation of Nuclear Hormone Receptors by Endocrine Disrupting Chemicals: Mechanisms and Pathological Consequences of Exposure

J. M. Hall, Callie W. Greco, 2019, Cells.

The Aryl-hydrocarbon Receptor (AhR) as a Therapeutic Target in Human Breast Cancer

J. M. Hall, 2013 .

The Aryl-hydrocarbon Receptor (AhR) as a Therapeutic Target in Human Breast

J. M. Hall, 2014 .

COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms

Xi-Ping Huang, B. Roth, D. Ricke, 2021, Frontiers in Pharmacology.

Aryl Hydrocarbon Receptor Regulates Cell Cycle Progression in Human Breast Cancer Cells via a Functional Interaction with Cyclin-Dependent Kinase 4

Russell S. Thomas, J. M. Hall, Melissa A. Barhoover, 2010, Molecular Pharmacology.

Molecular Determinants of the Stereoselectivity of Agonist Activity of Estrogen Receptors (ER) α and β*

S. O. Mueller, K. Korach, L. Pedersen, 2003, The Journal of Biological Chemistry.

COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms

Xi-Ping Huang, B. Roth, D. Ricke, 2020 .

Calcitonin gene-related peptide--a new concept in receptor-ligand specificity?

D. Smith, J. Hall, J. M. Hall, 1998, Trends in pharmacological sciences.

Development of Peptide Antagonists That Target Estrogen Receptor β-Coactivator Interactions

D. McDonnell, J. Hall, Ching-Yi Chang, 2000 .

The Molecular Mechanisms Underlying the Pro-Inflammatory Actions of Thiazolidinediones ( TZDs ) in Human Macrophages

D. McDonnell, J. M. Hall, 2007 .

The Estrogen Receptor β-Isoform (ERβ) of the Human Estrogen Receptor Modulates ERα Transcriptional Activity and Is a Key Regulator of the Cellular Response to Estrogens and Antiestrogens1.

D. McDonnell, J. M. Hall, Donald P. McDonnell, 1999, Endocrinology.

Endocrine disrupting chemicals promote the growth of ovarian cancer cells via the ER‐CXCL12‐CXCR4 signaling axis

K. Korach, J. M. Hall, 2013, Molecular carcinogenesis.

Research Resource: STR DNA profile and gene expression comparisons of human BG-1 cells and a BG-1/MCF-7 clonal variant.

K. Korach, Liwen Liu, S. Burkett, 2014, Molecular endocrinology.